Our experience in Healthcare Sectors M&A & inward investments
As Healthcare sector corporate finance and strategic growth advisors, we have worked with a range of companies across the breadth of the industry, covering:
- Women’s health and Fertility
- Healthcare Services
- Laboratory technology and equipment
Drivers of M&A in the Healthcare sectors
The healthcare sector is rapidly evolving to meet the challenges and opportunities of changing patient demographics, availability of care, evolving consumer expectations and complex and innovative technology used in diagnostics and delivery of healthcare services.
We have seen that the current Covid-19 pandemic has accelerated healthcare companies’ focus on technology and remote and ‘out-of-hospital’ care wherever possible. We are also seeing a rise in the attractiveness of private healthcare providers as the NHS has been forced to become increasingly focused on Covid measures and mitigations.
Acquiror Insights in the Healthcare Industries
Acquirers in the healthcare sectors focus their M&A activities on the broader MedTech space, including digital health and the use of technology in the provision of healthcare services, as well as delivery of care in the community or home settings.
Established healthcare providers are increasingly setting up venture capital arms to support their investment in technology and innovation, an example being InHealth Ventures.
Dominant players we speak with in the healthcare sectors are looking to drive growth with expansion around their core competences, building “centres of excellence” and helping to drive traffic to their existing operations.
Niche providers are tending to stick to their specialisms and are using M&A to become the provider of choice.
By way of an example, the IVF/fertility market is becoming increasingly attractive for private equity and is ripe for consolidation with major international IVF companies expanding their foothold into new geographic markets through M&A.